- Antiviral drug and its pharmaceutical composition
-
The invention relates to an antiviral medicine and a medicine composition thereof, in particular relates to an anti-human immunodeficiency virus (HIV) medicine and a medicine composition thereof, and especially relates to a medicine which can be taken as
- -
-
-
- New approaches to the industrial synthesis of HIV protease inhibitors
-
Efficient and industrially applicable synthetic processes for precursors of HIV protease inhibitors (Amprenavir, Fosamprenavir) are described. These involve a novel and economical method for the preparation of a key intermediate, (3S)-hydroxytetrahydrofuran, from L-malic acid. Three new approaches to the assembly of Amprenavir are also discussed. Of these, a synthetic route in which an (S)-tetrahydrofuranyloxy carbonyl is attached to L-phenylalanine appears to be the most promising manufacturing process, in that it offers satisfactory stereoselectivity in fewer steps.
- Honda, Yutaka,Katayama, Satoshi,Kojima, Mitsuhiko,Suzuki, Takayuki,Kishibata, Naomi,Izawa, Kunisuke
-
p. 2061 - 2070
(2007/10/03)
-
- Process for preparing oxiranemethanamine derivatives
-
A process for preparing oxiranemethane derivatives which are useful as intermediates for preparing aspartyl protease inhibitors comprising the steps of activating an aminodiol, acylating the aminodiol and reacting the acylated aminodiol with a base to form an epoxy compound.
- -
-
-
- Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
-
The present invention discloses the compounds of general formula (1) STR1 wherein R1, R2, R3 are optionally substituted carbonyl and amide derivatives which are useful as inhibitors of retroviral proteases, and are effecti
- -
-
-
- RETROVIRAL PROTEASE INHIBITING COMPOUNDS
-
A retroviral protease inhibiting compound of the formula: STR1 is disclosed wherein R 1, R 2, R 5, R 6, Y m and Y' n are herein defined.
- -
-
-
- Trifluoromethyl-containing pseudopeptides active against retroviruses
-
The present invention relates to new trifluoromethyl-containing pseudopeptides of the general formula (I) STR1 in which W, A, B, D, E, R 1, R 2 and R 3 have the meaning as outlined of their making and use as pharmaceuticals.
- -
-
-